本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Vor Biopharma Inc.

0.6614
+0.00040.06%
盘后0.69300.0316+4.78%19:59 EDT
成交量:18.76万
成交额:12.81万
市值:8,257.68万
市盈率:-0.39
高:0.6929
开:0.6700
低:0.6614
收:0.6610
数据加载中...
2022/03/14

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/11/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/17

重要事件披露

8-K - Current report
2021/05/06

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/03/25

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/19

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/02/19

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/02/09

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/09

重要事件披露

8-K - Current report
2021/02/03

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/02/03

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/02/02

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/02

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/01

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/01

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/01/21

SEC问询函

CORRESP [Cover] - Correspondence
2021/01/15

SEC问询函

CORRESP [Cover] - Correspondence
2021/01/15

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933